SCHEMBL9727666

SCHEMBL9727666

C=CCc1cc2c(cc1O)C(C)(C)C(O)O2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.38
GABRB2 P47870 2/20 0.38
SRD5A1 P18405 1/20 0.36
POLB P06746 2/20 0.34
HSD17B1 P14061 2/20 0.34
MEN1 O00255 1/20 0.32
ALOX5 P09917 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
GABRB1 P18505 1/20 0.32
RXRA P19793 1/20 0.32
CNR1 P21554 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
CNR2 P34972 1/20 0.32
GABRA2 P47869 1/20 0.32
KMT2A Q03164 1/20 0.32
ACE2 Q9BYF1 1/20 0.32
SIRT3 Q9NTG7 1/20 0.32
PTPN1 P18031 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9727746 0.82 GABRA1 (0.36) GABRA1GABRB2SRD5A1POLBHSD17B1
SCHEMBL9727754 0.81 GABRA1 (0.35) GABRA1GABRB2SRD5A1POLBHSD17B1
SCHEMBL9727707 0.75 PTPN1 (0.37) SRD5A1PTPN1
SCHEMBL1420694 0.68 GABRA1 (0.64) GABRA1GABRB2SRD5A1POLBMEN1
SCHEMBL1276635 0.68 CYP3A4 (0.55) GABRA1GABRB2SRD5A1POLBMEN1
SCHEMBL6309438 0.66 GABRA1 (0.61) GABRA1GABRB2SRD5A1POLBMEN1
SCHEMBL1244606 0.64 GABRA1 (0.59) GABRA1GABRB2SRD5A1POLBMEN1
SCHEMBL7737611 0.64 GABRA1 (0.59) GABRA1GABRB2SRD5A1POLBMEN1
SCHEMBL1975607 0.63 GABRA1 (0.53) GABRA1GABRB2SRD5A1POLBMEN1
SCHEMBL10404595 0.63 GABRA1 (0.33) GABRA1GABRB2SRD5A1POLBCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5091533-A Treating allergies, cardiovascular disorders, inflammation MERCK FROSST CANADA, INC. (CA) 1992-02-25 US disclosed
EP-0447189-A1 5-Hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors MERCK FROSST CANADA INC. (CA) 1991-09-18 EP disclosed